Pliant Therapeutics Inc.

NASDAQ: PLRX · Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT

Pliant Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-210.3M -161.34M -123.32M -97.26M
Depreciation & Amortization
2.13M 1.84M 1.82M 1.53M
Stock-Based Compensation
37.63M 44.48M 22.6M 10.44M
Other Working Capital
7.66M -3.7M 5.55M -1.25M
Other Non-Cash Items
5.96M -2.6M 52K 2.93M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
9.09M 1.25M 4.22M 6.92M
Operating Cash Flow
-155.5M -116.36M -94.63M -75.44M
Capital Expenditures
-3.85M -921K -1.76M -1.95M
Cash Acquisitions
n/a n/a 148.44M -75.65M
Purchase of Investments
-211.28M -583.07M -325.72M -219.89M
Sales Maturities Of Investments
355.47M 456.98M 177.27M 295.54M
Other Investing Acitivies
n/a n/a -148.44M 75.65M
Investing Cash Flow
140.34M -127.01M -150.2M 73.7M
Debt Repayment
19.91M n/a 10M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 5M 1.21M -457K
Financial Cash Flow
23.12M 274.4M 226.85M 2.53M
Net Cash Flow
7.95M 31.03M -17.98M 783K
Free Cash Flow
-159.35M -117.28M -96.39M -77.4M